Harlan Levine, M.D., is the president of health innovation and policy at City of Hope (COH), a National Cancer Institute-Designated Comprehensive Cancer Center dedicated to ensuring optimal cancer care through patient focused treatments. Dr. Levine also serves as the chair of the board of AccessHope™, a spinout company from COH that is focused on serving the employer market and making leading-edge cancer care available to all regardless of geographical location.
Although the revolutionary work of my colleagues has contributed to a 33% reduction in the cancer death rate over the last three decades, too many patients – particularly the most vulnerable – still never benefit from these innovations.